ES2054098T3 - Uso de minoxidilo para la curacion de heridas. - Google Patents

Uso de minoxidilo para la curacion de heridas.

Info

Publication number
ES2054098T3
ES2054098T3 ES89913018T ES89913018T ES2054098T3 ES 2054098 T3 ES2054098 T3 ES 2054098T3 ES 89913018 T ES89913018 T ES 89913018T ES 89913018 T ES89913018 T ES 89913018T ES 2054098 T3 ES2054098 T3 ES 2054098T3
Authority
ES
Spain
Prior art keywords
minoxidyl
healing
wounds
methods
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89913018T
Other languages
English (en)
Inventor
Anthony C Sank
George R Martin
Steven R Ledbetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Pharmacia and Upjohn Co
Original Assignee
US Department of Health and Human Services
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, Upjohn Co filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2054098T3 publication Critical patent/ES2054098T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

UN USO DE MINOXIDILO EN UN METODO PARA LA PROMOCION O ACELERACION DE CURACION DE HERIDAS. EL MINOXIDILO PUEDE ADMINISTRARSE POR APLICACION TOPICA, ADMINISTRACION ORAL, INYECCION O CUALQUIER COMBINACION DE ESTOS METODOS. EL TRATAMIENTO CON MINOXIDILO ES EFECTIVO PARA PROMOVER LA MIGRACION DE CELULAS EPITELIALES EN UNA HERIDA O EN TEJIDOS COMO LA CORNEA O SIMILARES. SE DESCRIBEN METODOS PARA IDENTIFICAR LOS LUGARES DE LIGADURA PARA MINOXIDILO EN CELULAS BASADAS EN SU AFINIDAD CON EL COMPUESTO EN PRUEBAS DE ADHESION O QUIMIOTACTICAS.
ES89913018T 1988-12-07 1989-12-01 Uso de minoxidilo para la curacion de heridas. Expired - Lifetime ES2054098T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/281,129 US4912111A (en) 1988-12-07 1988-12-07 Use of minoxidil for wound healing

Publications (1)

Publication Number Publication Date
ES2054098T3 true ES2054098T3 (es) 1994-08-01

Family

ID=23076064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89913018T Expired - Lifetime ES2054098T3 (es) 1988-12-07 1989-12-01 Uso de minoxidilo para la curacion de heridas.

Country Status (8)

Country Link
US (1) US4912111A (es)
EP (1) EP0447414B1 (es)
JP (1) JPH0717508B2 (es)
AT (1) ATE86488T1 (es)
AU (1) AU4626389A (es)
DE (1) DE68905342T2 (es)
ES (1) ES2054098T3 (es)
WO (1) WO1990006117A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114943A (en) * 1984-03-19 1992-05-19 The Rockefeller University Amino-substituted pyrimidines, derivatives and methods of use therefor
US5514676A (en) * 1984-03-19 1996-05-07 The Rockefeller University Amino-benzoic acids and derivatives, and methods of use
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
WO1991000907A1 (en) * 1989-07-05 1991-01-24 Emory University Monocyte chemotactic proteins and related peptides
US5328913A (en) * 1992-12-11 1994-07-12 Duke University Minoxidil analogs as inhibitors of cell proliferation and lysyl hydroxylase
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US7705010B2 (en) * 2005-02-22 2010-04-27 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
US20070270336A1 (en) * 2006-05-12 2007-11-22 Shiseido Company, Ltd. Method for accelerating cutaneous barrier recovery
US10143694B2 (en) 2006-10-27 2018-12-04 Matthew H. Kopacki Advanced formulations and therapies for treating hard-to-heal wounds
US20090170857A1 (en) * 2006-10-27 2009-07-02 Kopacki Matthew H Method for healing a wound using a direct vasodilator
US20090163504A1 (en) * 2006-10-27 2009-06-25 Kopacki Matthew H Method for healing a wound using a phosphodiesterase type five inhibitor
US8470833B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
KR102017796B1 (ko) * 2016-07-28 2019-09-03 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
WO2018049174A1 (en) * 2016-09-08 2018-03-15 Synergistic Therapeutics, Llc Topical hair growth formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth

Also Published As

Publication number Publication date
EP0447414B1 (en) 1993-03-10
EP0447414A1 (en) 1991-09-25
ATE86488T1 (de) 1993-03-15
US4912111A (en) 1990-03-27
AU4626389A (en) 1990-06-26
WO1990006117A1 (en) 1990-06-14
DE68905342D1 (de) 1993-04-15
JPH0717508B2 (ja) 1995-03-01
JPH04505751A (ja) 1992-10-08
DE68905342T2 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
ES2054098T3 (es) Uso de minoxidilo para la curacion de heridas.
DE59309635D1 (de) Topische Arzneiformen mit Insulin
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
DE69025943D1 (de) Verwendung von Spiperone-derivate zur Immunosuppression
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
ES2059965T3 (es) Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
DE3872372T2 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
CY1104971T1 (el) Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους
KR960701648A (ko) Pdgf와 비타민 d를 함유하는 조골세포 성장 자극 조성물(oesteoblast growth stimulating compostion containing pdgf and vitamind)
DK0460062T3 (da) Huperzin A-analoger
DK324687A (da) Transdermalt farmeceutisk praeparat
DE3485100D1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
DE69133077T2 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
DK0533210T3 (da) Protein C-holdige farmaceutiske præparater som midler mod inflammation.
KR950702432A (ko) 라이소자임 이량체와 이를 포함하는 조성물(Lysozyme dimer and compositions containing the same)
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
SE9303612D0 (sv) New use
KR970032815A (ko) 구강내 염증 치료용 조성물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 447414

Country of ref document: ES